Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
Zilganersen sodium by Ionis Pharmaceuticals for Alexander Disease: Likelihood of Approval
Zilganersen sodium is under clinical development by Ionis Pharmaceuticals and currently in Phase III for Alexander Disease. According to GlobalData,...